MobileODT is pioneering important new approaches to diagnostics and disease management while staying directly in the current of emerging technology.
Sphingotec develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to support patient management and provide guidance for treatment strategies.
Sight Sciences is a developer of glaucoma implants for the treatment of irreversible blindness.
Tel Aviv-Yafo, IL HQ
Menlo Park, US HQ
Twitter followers1.1 k
Alexa Website Rank
Alexa Website Rank583488
Alexa Website Rank986774
Alexa Website Rank436742
Latest funding round
Latest funding round$ 6.9m (over 2 years ago)
Latest funding round$ 23m (about 1 year ago)
Latest funding round$ 31m (3 months ago)
Total funding raised
Total funding raised$ 9.9m
Total funding raised$ 25.3m
Total funding raised$ 55.5m